TOR kinase complexes and cell migration

Journal of Cell Biology

Volumn 194, Issue 6, 2011, Pages 815-824

  Liu, Lunhua ^a   Parent, Carole A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; GROWTH FACTOR RECEPTOR; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; RHEB PROTEIN; TARGET OF RAPAMYCIN COMPLEX 1; TARGET OF RAPAMYCIN COMPLEX 2; TARGET OF RAPAMYCIN KINASE; TUBERIN; UNCLASSIFIED DRUG;

CELL MIGRATION; CHEMOTAXIS; CYTOSKELETON; DICTYOSTELIUM DISCOIDEUM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAPTOR; REGULATORY MECHANISM; REVIEW; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL MOVEMENT; CYTOSKELETON; HUMANS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 80053955812     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201102090     Document Type: Review

References (140)

1. Abraham, R.T. 2001. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15:2177-2196. http://dx.doi.org/10.1101/gad.914401
2. Alarcon, C.M., J. Heitman, and M.E. Cardenas. 1999. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast. Mol. Biol. Cell. 10:2531-2546.
3. Alessi, D.R., L.R. Pearce, and J.M. García-Martínez. 2009. New insights into mTOR signaling: mTORC2 and beyond. Sci. Signal. 2:pe27. http://dx.doi.org/10.1126/scisignal.267pe27
4. Andrade, M.A., and P. Bork. 1995. HEAT repeats in the Huntington's disease protein. Nat. Genet. 11:115-116. http://dx.doi.org/10.1038/ng1095-115
5. Attoub, S., V. Noe, L. Pirola, E. Bruyneel, E. Chastre, M. Mareel, M.P. Wymann, and C. Gespach. 2000. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and racdependent signaling pathways. FASEB J. 14:2329-2338. http://dx.doi.org/10.1096/fj.00-0162
6. Bagorda, A., and C.A. Parent. 2008. Eukaryotic chemotaxis at a glance. J. Cell Sci. 121:2621-2624. http://dx.doi.org/10.1242/jcs.018077
7. Bagorda, A., V.A. Mihaylov, and C.A. Parent. 2006. Chemotaxis: moving forward and holding on to the past. Thromb. Haemost. 95:12-21.
8. Bai, X., D. Ma, A. Liu, X. Shen, Q.J. Wang, Y. Liu, and Y. Jiang. 2007. Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science. 318:977-980. http://dx.doi.org/10.1126/science.1147379
9. Beretta, L., A.C. Gingras, Y.V. Svitkin, M.N. Hall, and N. Sonenberg. 1996. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits capdependent initiation of translation. EMBO J. 15:658-664.
10. Berven, L.A., F.S. Willard, and M.F. Crouch. 2004. Role of the p70(S6K) pathway in regulating the actin cytoskeleton and cell migration. Exp. Cell Res. 296:183-195. http://dx.doi.org/10.1016/j.yexcr.2003.12.032
11. Berzat, A., and A. Hall. 2010. Cellular responses to extracellular guidance cues. EMBO J. 29:2734-2745. http://dx.doi.org/10.1038/emboj.2010.170
12. Boffa, D.J., F. Luan, D. Thomas, H. Yang, V.K. Sharma, M. Lagman, and M. Suthanthiran. 2004. Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clin. Cancer Res. 10:293-300. http://dx.doi.org/10.1158/1078-0432.CCR-0629-3
13. Bosotti, R., A. Isacchi, and E.L. Sonnhammer. 2000. FAT: a novel domain in PIK-related kinases. Trends Biochem. Sci. 25:225-227. http://dx.doi.org/10.1016/S0968-0004(00)01563-2
14. Brunn, G.J., C.C. Hudson, A. Sekulić, J.M. Williams, H. Hosoi, P.J. Houghton, J.C. Lawrence Jr., and R.T. Abraham. 1997. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science. 277:99-101. http://dx.doi.org/10.1126/science.277.5322.99
15. Burnett, P.E., R.K. Barrow, N.A. Cohen, S.H. Snyder, and D.M. Sabatini. 1998. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. USA. 95:1432-1437. http://dx.doi.org/10.1073/pnas.95.4.1432
16. Cafferkey, R., M.M. McLaughlin, P.R. Young, R.K. Johnson, and G.P. Livi. 1994. Yeast TOR (DRR) proteins: amino-acid sequence alignment and identification of structural motifs. Gene. 141:133-136. http://dx.doi.org/10.1016/0378-1119(94)90141-4
17. Cai, H., S. Das, Y. Kamimura, Y. Long, C.A. Parent, and P.N. Devreotes. 2010. Ras-mediated activation of the TORC2-PKB pathway is critical for chemotaxis. J. Cell Biol. 190:233-245. http://dx.doi.org/10.1083/jcb.201001129
18. Charest, P.G., Z. Shen, A. Lakoduk, A.T. Sasaki, S.P. Briggs, and R.A. Firtel. 2010. A Ras signaling complex controls the RasC-TORC2 pathway and directed cell migration. Dev. Cell. 18:737-749. http://dx.doi.org/10.1016/j.devcel.2010.03.017
19. Chen, J., X.F. Zheng, E.J. Brown, and S.L. Schreiber. 1995. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. Proc. Natl. Acad. Sci. USA. 92:4947-4951. http://dx.doi.org/10.1073/pnas.92.11.4947
20. Chen, M.Y., Y. Long, and P.N. Devreotes. 1997. A novel cytosolic regulator, Pianissimo, is required for chemoattractant receptor and G protein-mediated activation of the 12 transmembrane domain adenylyl cyclase in Dictyostelium. Genes Dev. 11:3218-3231. http://dx.doi.org/10.1101/gad.11.23.3218
21. Choi, J.H., N.R. Adames, T.F. Chan, C. Zeng, J.A. Cooper, and X.F. Zheng. 2000. TOR signaling regulates microtubule structure and function. Curr. Biol. 10:861-864. http://dx.doi.org/10.1016/S0960-9822(00)00599-6
22. Citri, A., and Y. Yarden. 2006. EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell Biol. 7:505-516. http://dx.doi.org/10.1038/nrm1962
23. Dada, S., N. Demartines, and O. Dormond. 2008. mTORC2 regulates PGE2-mediated endothelial cell survival and migration. Biochem. Biophys. Res. Commun. 372:875-879. http://dx.doi.org/10.1016/j.bbrc.2008.05.154
24. Daniel, C., J. Pippin, S.J. Shankland, and C. Hugo. 2004. The rapamycin derivative RAD inhibits mesangial cell migration through the CDKinhibitor p27KIP1. Lab. Invest. 84:588-596. http://dx.doi.org/10.1038/labinvest.3700078
25. Das, G., A. Shiras, K. Shanmuganandam, and P. Shastry. 2011. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells. Mol. Carcinog. 50:412-423. http://dx.doi.org/10.1002/mc.20723
26. Denicourt, C., and S.F. Dowdy. 2004. Cip/Kip proteins: more than just CDKs inhibitors. Genes Dev. 18:851-855. http://dx.doi.org/10.1101/gad.1205304
27. Dibble, C.C., J.M. Asara, and B.D. Manning. 2009. Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol. Cell. Biol. 29:5657-5670. http://dx.doi.org/10.1128/MCB.00735-09
28. Eddy, R.J., L.M. Pierini, and F.R. Maxfield. 2002. Microtubule asymmetry during neutrophil polarization and migration. Mol. Biol. Cell. 13:4470-4483. http://dx.doi.org/10.1091/mbc.E02-04-0241
29. Fadri, M., A. Daquinag, S. Wang, T. Xue, and J. Kunz. 2005. The pleckstrin homology domain proteins Slm1 and Slm2 are required for actin cytoskeleton organization in yeast and bind phosphatidylinositol-4,5-bisphosphate and TORC2. Mol. Biol. Cell. 16:1883-1900. http://dx.doi.org/10.1091/mbc.E04-07-0564
30. Ferguson, G.J., L. Milne, S. Kulkarni, T. Sasaki, S. Walker, S. Andrews, T. Crabbe, P. Finan, G. Jones, S. Jackson, et al. 2007. PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesis. Nat. Cell Biol. 9:86-91. http://dx.doi.org/10.1038/ncb1517
31. Ferrara, N. 2002. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer. 2:795-803. http://dx.doi.org/10.1038/nrc909
32. Fonseca, B.D., E.M. Smith, V.H. Lee, C. MacKintosh, and C.G. Proud. 2007. PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex. J. Biol. Chem. 282:24514-24524. http://dx.doi.org/10.1074/jbc.M704406200
33. Friedl, P., and K. Wolf. 2010. Plasticity of cell migration: a multiscale tuning model. J. Cell Biol. 188:11-19. http://dx.doi.org/10.1083/jcb.200909003
34. Gan, X., J. Wang, B. Su, and D. Wu. 2011. Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 286:10998-11002. http://dx.doi.org/10.1074/jbc.M110.195016
35. Garami, A., F.J. Zwartkruis, T. Nobukuni, M. Joaquin, M. Roccio, H. Stocker, S.C. Kozma, E. Hafen, J.L. Bos, and G. Thomas. 2003. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell. 11:1457-1466. http://dx.doi.org/10.1016/S1097-2765(03)00220-X
36. García-Martínez, J.M., and D.R. Alessi. 2008. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem. J. 416:375-385. http://dx.doi.org/10.1042/BJ20081668
37. Gomez-Cambronero, J. 2003. Rapamycin inhibits GM-CSF-induced neutrophil migration. FEBS Lett. 550:94-100. http://dx.doi.org/10.1016/S0014-5793(03)00828-7
38. Guba, M., P. von Breitenbuch, M. Steinbauer, G. Koehl, S. Flegel, M. Hornung, C.J. Bruns, C. Zuelke, S. Farkas, M. Anthuber, et al. 2002. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat. Med. 8:128-135. http://dx.doi.org/10.1038/nm0202-128
39. Guertin, D.A., D.M. Stevens, C.C. Thoreen, A.A. Burds, N.Y. Kalaany, J. Moffat, M. Brown, K.J. Fitzgerald, and D.M. Sabatini. 2006. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev. Cell. 11:859-871. http://dx.doi.org/10.1016/j.devcel.2006.10.007
40. Gundersen, G.G., and J.C. Bulinski. 1988. Selective stabilization of microtubules oriented toward the direction of cell migration. Proc. Natl. Acad. Sci. USA. 85:5946-5950. http://dx.doi.org/10.1073/pnas.85.16.5946
41. Haghighat, A., S. Mader, A. Pause, and N. Sonenberg. 1995. Repression of capdependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J. 14:5701-5709.
42. Heasman, S.J., and A.J. Ridley. 2008. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 9:690-701. http://dx.doi.org/10.1038/nrm2476
43. Heitman, J., N.R. Movva, and M.N. Hall. 1991. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 253:905-909. http://dx.doi.org/10.1126/science.1715094
44. Helliwell, S.B., A. Schmidt, Y. Ohya, and M.N. Hall. 1998. The Rho1 effector Pkc1, but not Bni1, mediates signalling from Tor2 to the actin cytoskeleton. Curr. Biol. 8:1211-1214. http://dx.doi.org/10.1016/S0960-9822(07)00511-8
45. Hernández-Negrete, I., J. Carretero-Ortega, H. Rosenfeldt, R. Hernández-García, J.V. Calderón-Salinas, G. Reyes-Cruz, J.S. Gutkind, and J. Vázquez-Prado. 2007. P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration. J. Biol. Chem. 282:23708-23715. http://dx.doi.org/10.1074/jbc.M703771200
46. Hoekstra, M.F. 1997. Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family. Curr. Opin. Genet. Dev. 7:170-175. http://dx.doi.org/10.1016/S0959-437X(97)80125-6
47. Huang, J., and B.D. Manning. 2008. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem. J. 412:179-190. http://dx.doi.org/10.1042/BJ20080281
48. Inoki, K., Y. Li, T. Zhu, J. Wu, and K.L. Guan. 2002. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4:648-657. http://dx.doi.org/10.1038/ncb839
49. Inoki, K., Y. Li, T. Xu, and K.L. Guan. 2003a. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17:1829-1834. http://dx.doi.org/10.1101/gad.1110003
50. Inoki, K., T. Zhu, and K.L. Guan. 2003b. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 115:577-590. http://dx.doi.org/10.1016/S0092-8674(03)00929-2
51. Inoki, K., H. Ouyang, T. Zhu, C. Lindvall, Y. Wang, X. Zhang, Q. Yang, C. Bennett, Y. Harada, K. Stankunas, et al. 2006. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell. 126:955-968. http://dx.doi.org/10.1016/j.cell.2006.06.055
52. Jacinto, E., and A. Lorberg. 2008. TOR regulation of AGC kinases in yeast and mammals. Biochem. J. 410:19-37. http://dx.doi.org/10.1042/BJ20071518
53. Jacinto, E., R. Loewith, A. Schmidt, S. Lin, M.A. Rüegg, A. Hall, and M.N. Hall. 2004. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6:1122-1128. http://dx.doi.org/10.1038/ncb1183
54. Jacinto, E., V. Facchinetti, D. Liu, N. Soto, S. Wei, S.Y. Jung, Q. Huang, J. Qin, and B. Su. 2006. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell. 127:125-137. http://dx.doi.org/10.1016/j.cell.2006.08.033
55. Jaffe, A.B., and A. Hall. 2005. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21:247-269. http://dx.doi.org/10.1146/annurev.cellbio.21.020604.150721
56. Jiang, X., and R.S. Yeung. 2006. Regulation of microtubule-dependent protein transport by the TSC2/mammalian target of rapamycin pathway. Cancer Res. 66:5258-5269. http://dx.doi.org/10.1158/0008-5472.CAN-05-4510
57. Julien, L.A., A. Carriere, J. Moreau, and P.P. Roux. 2010. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. Mol. Cell. Biol. 30:908-921. http://dx.doi.org/10.1128/MCB.00601-09
58. Kamada, Y., U.S. Jung, J. Piotrowski, and D.E. Levin. 1995. The protein kinase C-activated MAP kinase pathway of Saccharomyces cerevisiae mediates a novel aspect of the heat shock response. Genes Dev. 9:1559-1571. http://dx.doi.org/10.1101/gad.9.13.1559
59. Kamada, Y., H. Qadota, C.P. Python, Y. Anraku, Y. Ohya, and D.E. Levin. 1996. Activation of yeast protein kinase C by Rho1 GTPase. J. Biol. Chem. 271:9193-9196. http://dx.doi.org/10.1074/jbc.271.16.9193
60. Kamada, Y., Y. Fujioka, N.N. Suzuki, F. Inagaki, S. Wullschleger, R. Loewith, M.N. Hall, and Y. Ohsumi. 2005. Tor2 directly phosphorylates the AGC kinase Ypk2 to regulate actin polarization. Mol. Cell. Biol. 25:7239-7248. http://dx.doi.org/10.1128/MCB.25.16.7239-7248.2005
61. Kamimura, Y., Y. Xiong, P.A. Iglesias, O. Hoeller, P. Bolourani, and P.N. Devreotes. 2008. PIP3-independent activation of TorC2 and PKB at the cell's leading edge mediates chemotaxis. Curr. Biol. 18:1034-1043. http://dx.doi.org/10.1016/j.cub.2008.06.068
62. Kantidakis, T., B.A. Ramsbottom, J.L. Birch, S.N. Dowding, and R.J. White. 2010. mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1. Proc. Natl. Acad. Sci. USA. 107:11823-11828. http://dx.doi.org/10.1073/pnas.1005188107
63. Khandoga, A., J.S. Kessler, M. Hanschen, A.G. Khandoga, D. Burggraf, C. Reichel, G.F. Hamann, G. Enders, and F. Krombach. 2006. Matrix metalloproteinase-9 promotes neutrophil and T cell recruitment and migration in the postischemic liver. J. Leukoc. Biol. 79:1295-1305. http://dx.doi.org/10.1189/jlb.0805468
64. Kim, D.H., D.D. Sarbassov, S.M. Ali, J.E. King, R.R. Latek, H. Erdjument-Bromage, P. Tempst, and D.M. Sabatini. 2002. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 110:163-175. http://dx.doi.org/10.1016/S0092-8674 (02)00808-5
65. Kim, D.H., D.D. Sarbassov, S.M. Ali, R.R. Latek, K.V. Guntur, H. Erdjument-Bromage, P. Tempst, and D.M. Sabatini. 2003. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol. Cell. 11:895-904. http://dx.doi.org/10.1016/S1097-2765(03)00114-X
66. King, J.S., and R.H. Insall. 2009. Chemotaxis: finding the way forward with Dictyostelium. Trends Cell Biol. 19:523-530. http://dx.doi.org/10.1016/j.tcb.2009.07.004
67. Kobayashi, S., T. Kishimoto, S. Kamata, M. Otsuka, M. Miyazaki, and H. Ishikura. 2007. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis. Cancer Sci. 98:726-733. http://dx.doi.org/10.1111/j.1349-7006.2007.00439.x
68. Koltin, Y., L. Faucette, D.J. Bergsma, M.A. Levy, R. Cafferkey, P.L. Koser, R.K. Johnson, and G.P. Livi. 1991. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein. Mol. Cell. Biol. 11:1718-1723.
69. Kriebel, P.W., V.A. Barr, E.C. Rericha, G. Zhang, and C.A. Parent. 2008. Collective cell migration requires vesicular trafficking for chemoattractant delivery at the trailing edge. J. Cell Biol. 183:949-961. http://dx.doi.org/10.1083/jcb.200808105
70. Kuehn, H.S., M.Y. Jung, M.A. Beaven, D.D. Metcalfe, and A.M. Gilfillan. 2011. Prostaglandin E2 activates and utilizes mTORC2 as a central signaling locus for the regulation of mast cell chemotaxis and mediator release. J. Biol. Chem. 286:391-402. http://dx.doi.org/10.1074/jbc.M110.164772
71. Kunz, J., U. Schneider, I. Howald, A. Schmidt, and M.N. Hall. 2000. HEAT repeats mediate plasma membrane localization of Tor2p in yeast. J. Biol. Chem. 275:37011-37020. http://dx.doi.org/10.1074/jbc.M007296200
72. Kupfer, A., D. Louvard, and S.J. Singer. 1982. Polarization of the Golgi apparatus and the microtubule-organizing center in cultured fibroblasts at the edge of an experimental wound. Proc. Natl. Acad. Sci. USA. 79:2603-2607. http://dx.doi.org/10.1073/pnas.79.8.2603
73. Kurokawa, K., and M. Matsuda. 2005. Localized RhoA activation as a requirement for the induction of membrane ruffling. Mol. Biol. Cell. 16:4294-4303. http://dx.doi.org/10.1091/mbc.E04-12-1076
74. Laplante, M., and D.M. Sabatini. 2009. mTOR signaling at a glance. J. Cell Sci. 122:3589-3594. http://dx.doi.org/10.1242/jcs.051011
75. Le Clainche, C., and M.F. Carlier. 2008. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol. Rev. 88:489-513. http://dx.doi.org/10.1152/physrev.00021.2007
76. Lee, S., C.A. Parent, R. Insall, and R.A. Firtel. 1999. A novel Ras-interacting protein required for chemotaxis and cyclic adenosine monophosphate signal relay in Dictyostelium. Mol. Biol. Cell. 10:2829-2845.
77. Lee, S., F.I. Comer, A. Sasaki, I.X. McLeod, Y. Duong, K. Okumura, J.R. Yates III, C.A. Parent, and R.A. Firtel. 2005. TOR complex 2 integrates cell movement during chemotaxis and signal relay in Dictyostelium. Mol. Biol. Cell. 16:4572-4583. http://dx.doi.org/10.1091/mbc.E05-04-0342
78. Liu, L., F. Li, J.A. Cardelli, K.A. Martin, J. Blenis, and S. Huang. 2006. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways. Oncogene. 25:7029-7040. http://dx.doi.org/10.1038/sj.onc.1209691
79. Liu, L., L. Chen, J. Chung, and S. Huang. 2008. Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins. Oncogene. 27:4998-5010. http://dx.doi.org/10.1038/onc.2008.137
80. Liu, L., S. Das, W. Losert, and C.A. Parent. 2010a. mTORC2 regulates neutrophil chemotaxis in a cAMP- and RhoA-dependent fashion. Dev. Cell. 19:845-857. http://dx.doi.org/10.1016/j.devcel.2010.11.004
81. Liu, L., Y. Luo, L. Chen, T. Shen, B. Xu, W. Chen, H. Zhou, X. Han, and S. Huang. 2010b. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity. J. Biol. Chem. 285:38362-38373. http://dx.doi.org/10.1074/jbc.M110.141168
82. Loewith, R., E. Jacinto, S. Wullschleger, A. Lorberg, J.L. Crespo, D. Bonenfant, W. Oppliger, P. Jenoe, and M.N. Hall. 2002. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell. 10:457-468. http://dx.doi.org/10.1016/S1097-2765 (02)00636-6
83. Luan, F.L., R. Ding, V.K. Sharma, W.J. Chon, M. Lagman, and M. Suthanthiran. 2003. Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int. 63:917-926. http://dx.doi.org/10.1046/j.1523-1755.2003.00805.x
84. Ma, L., Z. Chen, H. Erdjument-Bromage, P. Tempst, and P.P. Pandolfi. 2005. Phosphorylation and functional inactivation of TSC2 by Erk implicationsfor tuberous sclerosis and cancer pathogenesis. Cell. 121:179-193. http://dx.doi.org/10.1016/j.cell.2005.02.031
85. Marston, D.J., and B. Goldstein. 2006. Actin-based forces driving embryonic morphogenesis in Caenorhabditis elegans. Curr. Opin. Genet. Dev. 16:392-398. http://dx.doi.org/10.1016/j.gde.2006.06.002
86. Masri, J., A. Bernath, J. Martin, O.D. Jo, R. Vartanian, A. Funk, and J. Gera. 2007. mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. Cancer Res. 67:11712-11720. http://dx.doi.org/10.1158/0008-5472.CAN-07-2223
87. McDonald, P.C., A. Oloumi, J. Mills, I. Dobreva, M. Maidan, V. Gray, E.D. Wederell, M.B. Bally, L.J. Foster, and S. Dedhar. 2008. Rictor and integrinlinked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res. 68:1618-1624. http://dx.doi.org/10.1158/0008-5472.CAN-07-5869
88. McMahon, L.P., K.M. Choi, T.A. Lin, R.T. Abraham, and J.C. Lawrence Jr. 2002. The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin. Mol. Cell. Biol. 22:7428-7438. http://dx.doi.org/10.1128/MCB.22.21.7428-7438.2002
89. Meili, R., C. Ellsworth, and R.A. Firtel. 2000. A novel Akt/PKB-related kinase is essential for morphogenesis in Dictyostelium. Curr. Biol. 10:708-717. http://dx.doi.org/10.1016/S0960-9822(00)00536-4
90. Michels, A.A., A.M. Robitaille, D. Buczynski-Ruchonnet, W. Hodroj, J.H. Reina, M.N. Hall, and N. Hernandez. 2010. mTORC1 directly phosphorylates and regulates human MAF1. Mol. Cell. Biol. 30:3749-3757. http://dx.doi.org/10.1128/MCB.00319-10
91. Montell, D.J. 2006. The social lives of migrating cells in Drosophila. Curr. Opin. Genet. Dev. 16:374-383. http://dx.doi.org/10.1016/j.gde.2006.06.010
92. Mora, A., D. Komander, D.M. van Aalten, and D.R. Alessi. 2004. PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 15:161-170. http://dx.doi.org/10.1016/j.semcdb.2003.12.022
93. Moss, S.C., D.J. Lightell Jr., S.O. Marx, A.R. Marks, and T.C. Woods. 2010. Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor p27Kip1. J. Biol. Chem. 285:11991-11997. http://dx.doi.org/10.1074/jbc.M109.066621
94. Murooka, T.T., R. Rahbar, L.C. Platanias, and E.N. Fish. 2008. CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1. Blood. 111:4892-4901. http://dx.doi.org/10.1182/blood-2007-11-125039
95. Navé, B.T., M. Ouwens, D.J. Withers, D.R. Alessi, and P.R. Shepherd. 1999. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 344:427-431. http://dx.doi.org/10.1042/0264-6021:3440427
96. Palazzo, A.F., C.H. Eng, D.D. Schlaepfer, E.E. Marcantonio, and G.G. Gundersen. 2004. Localized stabilization of microtubules by integrinand FAK-facilitated Rho signaling. Science. 303:836-839. http://dx.doi.org/10.1126/science.1091325
97. Parsons, J.T., A.R. Horwitz, and M.A. Schwartz. 2010. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat. Rev. Mol. Cell Biol. 11:633-643. http://dx.doi.org/10.1038/nrm2957
98. Pearce, L.R., X. Huang, J. Boudeau, R. Pawłowski, S. Wullschleger, M. Deak, A.F. Ibrahim, R. Gourlay, M.A. Magnuson, and D.R. Alessi. 2007. Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Biochem. J. 405:513-522. http://dx.doi.org/10.1042/BJ20070540
99. Pearce, L.R., D. Komander, and D.R. Alessi. 2010. The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 11:9-22. http://dx.doi.org/10.1038/nrm2822
100. Pearson, R.B., P.B. Dennis, J.W. Han, N.A. Williamson, S.C. Kozma, R.E. Wettenhall, and G. Thomas. 1995. The principal target of rapamycininduced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J. 14:5279-5287.
101. Perry, J., and N. Kleckner. 2003. The ATRs, ATMs, and TORs are giant HEAT repeat proteins. Cell. 112:151-155. http://dx.doi.org/10.1016/S0092-8674(03)00033-3
102. Peterson, T.R., M. Laplante, C.C. Thoreen, Y. Sancak, S.A. Kang, W.M. Kuehl, N.S. Gray, and D.M. Sabatini. 2009. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell. 137:873-886. http://dx.doi.org/10.1016/j.cell.2009.03.046
103. Poon, M., S.O. Marx, R. Gallo, J.J. Badimon, M.B. Taubman, and A.R. Marks. 1996. Rapamycin inhibits vascular smooth muscle cell migration. J. Clin. Invest. 98:2277-2283. http://dx.doi.org/10.1172/JCI119038
104. Ratner, S., W.S. Sherrod, and D. Lichlyter. 1997. Microtubule retraction into the uropod and its role in T cell polarization and motility. J. Immunol. 159:1063-1067.
105. Ridley, A.J., M.A. Schwartz, K. Burridge, R.A. Firtel, M.H. Ginsberg, G. Borisy, J.T. Parsons, and A.R. Horwitz. 2003. Cell migration: integrating signals from front to back. Science. 302:1704-1709. http://dx.doi.org/10.1126/science.1092053
106. Roux, P.P., B.A. Ballif, R. Anjum, S.P. Gygi, and J. Blenis. 2004. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. USA. 101:13489-13494. http://dx.doi.org/10.1073/pnas.0405659101
107. Saci, A., L.C. Cantley, and C.L. Carpenter. 2011. Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. Mol. Cell. 42:50-61. http://dx.doi.org/10.1016/j.molcel.2011.03.017
108. Sakakibara, K., B. Liu, S. Hollenbeck, and K.C. Kent. 2005. Rapamycin inhibits fibronectin-induced migration of the human arterial smooth muscle line (E47) through the mammalian target of rapamycin. Am. J. Physiol. Heart Circ. Physiol. 288:H2861-H2868. http://dx.doi.org/10.1152/ajpheart.00561.2004
109. Sarbassov, D.D., S.M. Ali, D.H. Kim, D.A. Guertin, R.R. Latek, H. Erdjument-Bromage, P. Tempst, and D.M. Sabatini. 2004. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14:1296-1302. http://dx.doi.org/10.1016/j.cub.2004.06.054
110. Sarbassov, D.D., D.A. Guertin, S.M. Ali, and D.M. Sabatini. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 307:1098-1101. http://dx.doi.org/10.1126/science.1106148
111. Sarbassov, D.D., S.M. Ali, S. Sengupta, J.H. Sheen, P.P. Hsu, A.F. Bagley, A.L. Markhard, and D.M. Sabatini. 2006. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell. 22:159-168. http://dx.doi.org/10.1016/j.molcel.2006.03.029
112. Schmidt, A., J. Kunz, and M.N. Hall. 1996. TOR2 is required for organization of the actin cytoskeleton in yeast. Proc. Natl. Acad. Sci. USA. 93:13780-13785. http://dx.doi.org/10.1073/pnas.93.24.13780
113. Schmidt, A., M. Bickle, T. Beck, and M.N. Hall. 1997. The yeast phosphatidylinositol kinase homolog TOR2 activates RHO1 and RHO2 via the exchange factor ROM2. Cell. 88:531-542. http://dx.doi.org/10.1016/ S0092-8674(00)81893-0
114. Scott, P.H., G.J. Brunn, A.D. Kohn, R.A. Roth, and J.C. Lawrence Jr. 1998. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA. 95:7772-7777. http://dx.doi.org/10.1073/pnas.95.13.7772
115. Sekulić, A., C.C. Hudson, J.L. Homme, P. Yin, D.M. Otterness, L.M. Karnitz, and R.T. Abraham. 2000. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 60:3504-3513.
116. Shiota, C., J.T. Woo, J. Lindner, K.D. Shelton, and M.A. Magnuson. 2006. Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev. Cell. 11:583-589. http://dx.doi.org/10.1016/j.devcel.2006.08.013
117. Shor, B., J. Wu, Q. Shakey, L. Toral-Barza, C. Shi, M. Follettie, and K. Yu. 2010. Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells. J. Biol. Chem. 285:15380-15392. http://dx.doi.org/10.1074/jbc.M109.071639
118. Sofer, A., K. Lei, C.M. Johannessen, and L.W. Ellisen. 2005. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol. Cell. Biol. 25:5834-5845. http://dx.doi.org/10.1128/MCB.25.14 .5834-5845.2005
119. Stephens, L., L. Milne, and P. Hawkins. 2008. Moving towards a better understanding of chemotaxis. Curr. Biol. 18:R485-R494. http://dx.doi.org/10.1016/j.cub.2008.04.048
120. Sun, J., S.O. Marx, H.J. Chen, M. Poon, A.R. Marks, and L.E. Rabbani. 2001. Role for p27(Kip1) in vascular smooth muscle cell migration. Circulation. 103:2967-2972.
121. Swaney, K.F., C.H. Huang, and P.N. Devreotes. 2010. Eukaryotic chemotaxis: a network of signaling pathways controls motility, directional sensing, and polarity. Annu Rev Biophys. 39:265-289. http://dx.doi.org/10.1146/annurev.biophys.093008.131228
122. Takahashi, T., K. Hara, H. Inoue, Y. Kawa, C. Tokunaga, S. Hidayat, K. Yoshino, Y. Kuroda, and K. Yonezawa. 2000. Carboxyl-terminal region conserved among phosphoinositide-kinase-related kinases is indispensable for mTOR function in vivo and in vitro. Genes Cells. 5:765-775. http://dx.doi.org/10.1046/j.1365-2443.2000.00365.x
123. Tee, A.R., B.D. Manning, P.P. Roux, L.C. Cantley, and J. Blenis. 2003. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13:1259-1268. http://dx.doi.org/10.1016/S0960-9822(03)00506-2
124. Toschi, A., E. Lee, L. Xu, A. Garcia, N. Gadir, and D.A. Foster. 2009. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid:competition with rapamycin. Mol. Cell. Biol. 29:1411-1420. http://dx.doi.org/10.1128/MCB.00782-08
125. Treins, C., P.H. Warne, M.A. Magnuson, M. Pende, and J. Downward. 2010. Rictor is a novel target of p70 S6 kinase-1. Oncogene. 29:1003-1016. http://dx.doi.org/10.1038/onc.2009.401
126. Turner, H.E., A.L. Harris, S. Melmed, and J.A. Wass. 2003. Angiogenesis in endocrine tumors. Endocr. Rev. 24:600-632. http://dx.doi.org/10.1210/er.2002-0008
127. Vaillant, C., C. Meissirel, M. Mutin, M.F. Belin, L.R. Lund, and N. Thomasset. 2003. MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum. Mol. Cell. Neurosci. 24:395-408. http://dx.doi.org/10.1016/S1044-7431(03)00196-9
128. Wan, X., A. Mendoza, C. Khanna, and L.J. Helman. 2005. Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma. Cancer Res. 65:2406-2411. http://dx.doi.org/10.1158/0008-5472.CAN-04-3135
129. Wang, F. 2009. The signaling mechanisms underlying cell polarity and chemotaxis. Cold Spring Harb. Perspect. Biol. 1:a002980. http://dx.doi.org/10.1101/cshperspect.a002980
130. Wang, L., T.E. Harris, R.A. Roth, and J.C. Lawrence Jr. 2007. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J. Biol. Chem. 282:20036-20044. http://dx.doi.org/10.1074/jbc .M702376200
131. Weijer, C.J. 2009. Collective cell migration in development. J. Cell Sci. 122:3215-3223. http://dx.doi.org/10.1242/jcs.036517
132. Wong, A.S., C.D. Roskelley, S. Pelech, D. Miller, P.C. Leung, and N. Auersperg. 2004. Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation. Exp. Cell Res. 299: 248-256. http://dx.doi.org/10.1016/j.yexcr.2004.06.002
133. Wong, K., A. Van Keymeulen, and H.R. Bourne. 2007. PDZRhoGEF and myosin II localize RhoA activity to the back of polarizing neutrophil-like cells. J. Cell Biol. 179:1141-1148. http://dx.doi.org/10.1083/jcb.200706167
134. Woo, S.Y., D.H. Kim, C.B. Jun, Y.M. Kim, E.V. Haar, S.I. Lee, J.W. Hegg, S. Bandhakavi, T.J. Griffin, and D.H. Kim. 2007. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling. J. Biol. Chem. 282:25604-25612. http://dx.doi.org/10.1074/jbc.M704343200
135. Wullschleger, S., R. Loewith, W. Oppliger, and M.N. Hall. 2005. Molecular organization of target of rapamycin complex 2. J. Biol. Chem. 280:30697-30704. http://dx.doi.org/10.1074/jbc.M505553200
136. Yang, Q., K. Inoki, T. Ikenoue, and K.L. Guan. 2006a. Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev. 20:2820-2832. http://dx.doi.org/10.1101/gad.1461206
137. Yang, Q., K. Inoki, E. Kim, and K.L. Guan. 2006b. TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. Proc. Natl. Acad. Sci. USA. 103:6811-6816. http://dx.doi.org/10.1073/pnas.0602282103
138. Zhang, F., X. Zhang, M. Li, P. Chen, B. Zhang, H. Guo, W. Cao, X. Wei, X. Cao, X. Hao, and N. Zhang. 2010. mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis. Cancer Res. 70:9360-9370. http://dx.doi.org/10.1158/0008-5472.CAN-10-0207
139. Zhou, H.Y., and A.S. Wong. 2006. Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells. Endocrinology. 147:2557-2566. http://dx.doi.org/10.1210/en.2005-1404
140. Zoncu, R., A. Efeyan, and D.M. Sabatini. 2011. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12:21-35. http://dx.doi.org/10.1038/nrm3025